Key Takeaways
- American Indians and Alaska Natives (AI/AN) have a diabetes prevalence rate of 14.5% among adults aged 18+, which is 2.3 times higher than the U.S. general population rate of 6.5%
- In 2019, AI/AN adults had a heart disease mortality rate of 200.9 per 100,000, 1.7 times higher than the white population's 118.5 per 100,000
- AI/AN people experience kidney failure at 3.5 times the rate of the general U.S. population, with an incidence of 224 per million versus 64 per million in 2020
- AI/AN adults report 28.4% with diagnosed depression, versus 20.1% U.S. average per 2021 NSDUH
- Suicide rate among AI/AN aged 10-34 is 33.1 per 100,000, 3.5 times the U.S. rate of 9.5 in 2021
- 25.7% of AI/AN adults experienced serious psychological distress in past month, vs 5.4% nationally per 2020 NSDUH
- Alcohol use disorder affects 15.8% of AI/AN adults past year, 1.5 times national 10.5% per 2021 NSDUH
- AI/AN have opioid overdose death rate of 65.2 per 100,000 in 2021, highest among races at 3.5x white rate
- 28.6% of AI/AN youth aged 12-17 binge drank in past month, vs 13.8% national per 2020 NSDUH
- HIV incidence among AI/AN is 5.7 per 100,000 in 2021, lower but higher late diagnosis at 45% vs 37% national
- Tuberculosis case rate in AI/AN is 5.2 per 100,000 in 2022, 4x general U.S. rate of 2.4
- COVID-19 death rate per 100k for AI/AN was 368 in 2020-2021, 2.1x Hispanic rate
- Only 45% of AI/AN have health insurance vs 92% U.S. adults per 2022 ACS
- IHS per capita spending is $4,078 vs $13,000 Medicare in 2021
- 23% of AI/AN report cost barrier to care vs 10% national per 2021 NHIS
Native Americans face disproportionately high rates of chronic disease and mental illness.
Chronic Diseases
- American Indians and Alaska Natives (AI/AN) have a diabetes prevalence rate of 14.5% among adults aged 18+, which is 2.3 times higher than the U.S. general population rate of 6.5%
- In 2019, AI/AN adults had a heart disease mortality rate of 200.9 per 100,000, 1.7 times higher than the white population's 118.5 per 100,000
- AI/AN people experience kidney failure at 3.5 times the rate of the general U.S. population, with an incidence of 224 per million versus 64 per million in 2020
- Obesity rates among AI/AN adults stand at 42.5%, compared to 31.6% in the general U.S. population in 2021 NHANES data
- AI/AN have a stroke mortality rate of 52.9 per 100,000, 1.5 times higher than non-Hispanic whites at 36.2 per 100,000 in 2018-2020
- Arthritis prevalence in AI/AN adults is 23.4%, higher than the national average of 17.6% per 2022 BRFSS data
- AI/AN cancer incidence rate is 432.3 per 100,000, with mortality at 160.4 per 100,000 versus U.S. all races 446.3 and 146.8 in 2020
- Hypertension affects 35.2% of AI/AN adults, compared to 30.1% nationally per 2019-2020 NHANES
- COPD death rate among AI/AN is 47.3 per 100,000, 1.4 times the white rate of 33.6 in 2021
- AI/AN youth aged 12-17 have 18.8% asthma prevalence, higher than 13.2% national average per 2021 NSCH
- Liver disease mortality in AI/AN is 39.2 per 100,000, 2.1 times higher than whites at 18.7 in 2019
- AI/AN adults diabetes prevalence 14.7% in Southwest tribes like Navajo per IHS 2022
- Heart disease death rate 245 per 100,000 in AI/AN Alaska Natives 2019
- End-stage renal disease incidence 450 per million in AI/AN Pima tribe vs 370 national 2020
- Obesity in AI/AN children 2-5 yo 15.4% vs 13.9% national NHANES 2019
- Cerebrovascular disease mortality 65.2 per 100,000 AI/AN 2018-2020 NVSS
- Colorectal cancer screening 52.3% in AI/AN 50-75 yo vs 67.3% national 2021 NHIS
- Chronic lower respiratory disease death 55.4 per 100k AI/AN 2021
- Cirrhosis mortality 28.5 per 100k AI/AN men 2019
Chronic Diseases Interpretation
Healthcare Access
- Only 45% of AI/AN have health insurance vs 92% U.S. adults per 2022 ACS
- IHS per capita spending is $4,078 vs $13,000 Medicare in 2021
- 23% of AI/AN report cost barrier to care vs 10% national per 2021 NHIS
- AI/AN travel 80+ miles for care 30% of time vs 10% rural U.S. per UAHI 2022
- Dental care unmet needs in AI/AN adults 34% vs 12% national per 2020 BRFSS
- 28% of AI/AN delayed medical care due to transportation vs 4% U.S. per 2019-2020 MEPS
- IHS facilities have 1 primary care provider per 2,500 users vs 1:1,500 national standard in 2023
- Telehealth use in AI/AN increased 300% but still only 25% of visits in 2022 per IHS
- AI/AN infant mortality rate is 9.1 per 1,000 live births, 1.7x national 5.4 in 2021
- Low birthweight in AI/AN is 8.2% vs 8.5% national but higher preterm at 11.5% per 2021 NVSR
- Maternal mortality ratio for AI/AN is 32.0 per 100,000 live births 2018-2021, 3x white rate
- AI/AN women prenatal care first trimester 72% vs 83% national per 2021 PRAMS
- Childhood obesity in AI/AN 6-11 yo is 23.1% vs 19.7% national per 2017-2020 NHANES
- AI/AN teen birth rate 25.4 per 1,000 females 15-19 vs 16.7 national 2021
- Diabetes in AI/AN pregnant women 10.5% vs 7.2% U.S. per 2020 birth data
- Primary care physician shortage in IHS areas 60% vacancy 2023
- Emergency department wait times 4.2 hours AI/AN facilities vs 2.5 national 2022
- Behavioral health provider ratio 1:5,000 AI/AN vs 1:380 national
- Pharmacy access limited, 25% IHS sites no pharmacist 2022
- AI/AN elder care home visits only 15% coverage per tribe reports
Healthcare Access Interpretation
Infectious Diseases
- HIV incidence among AI/AN is 5.7 per 100,000 in 2021, lower but higher late diagnosis at 45% vs 37% national
- Tuberculosis case rate in AI/AN is 5.2 per 100,000 in 2022, 4x general U.S. rate of 2.4
- COVID-19 death rate per 100k for AI/AN was 368 in 2020-2021, 2.1x Hispanic rate
- Hepatitis C prevalence in AI/AN is 1.2%, with high mortality 4.5 per 100k vs 1.8 national in 2021
- Chlamydia rates in AI/AN females 15-24 is 4,500 per 100k, highest racial group per 2021 CDC STD
- Gonorrhea incidence in AI/AN is 652 per 100k in 2021, 5x white rate of 128
- Syphilis congenital rate in AI/AN is 450 per 100k live births 2021, 6x national average
- HPV vaccination coverage in AI/AN adolescents is 54.2% complete series vs 59.3% national per NIS-Teen 2021
- Influenza hospitalization rate for AI/AN 2019-2020 was 25.4 per 100k, higher risk group per CDC FluView
- Hepatitis A incidence in AI/AN peaked at 15 per 100k in 2019 outbreak areas
- Pneumococcal pneumonia hospitalization AI/AN children 65 per 100k vs 12 national pre-vaccine
- COVID-19 hospitalization rate 2x higher AI/AN 65+ in 2022
- Gonorrhea rates 1,200 per 100k AI/AN Alaska 2021
- HPV-associated cancer incidence 15.2 per 100k AI/AN women
- Hantavirus pulmonary syndrome case fatality 38% in AI/AN Southwest
Infectious Diseases Interpretation
Mental Health
- AI/AN adults report 28.4% with diagnosed depression, versus 20.1% U.S. average per 2021 NSDUH
- Suicide rate among AI/AN aged 10-34 is 33.1 per 100,000, 3.5 times the U.S. rate of 9.5 in 2021
- 25.7% of AI/AN adults experienced serious psychological distress in past month, vs 5.4% nationally per 2020 NSDUH
- PTSD prevalence in AI/AN adults is estimated at 15.2%, higher than 6.8% in general population per NVSR
- AI/AN youth suicide attempt rate is 16.2% in past year for grades 9-12, vs 8.9% national per 2021 YRBS
- 22.1% of AI/AN adults have any mental illness, compared to 21.6% U.S. but with higher severity per 2019 NSDUH
- Anxiety disorders affect 12.4% of AI/AN adults annually, vs 9.6% nationally per NCS-A
- AI/AN veterans have 24.5% PTSD rate, higher than 13.5% overall veterans per NVVLS 2021
- Bipolar disorder lifetime prevalence in AI/AN is 4.2%, similar but undertreated vs 2.8% U.S. per NESARC
- Schizophrenia prevalence in AI/AN is 1.3%, with disparities in access per 2020 ECA data
- AI/AN adults major depressive episode past year 9.5% vs 7.1% national NSDUH 2021
- AI/AN suicide rate 25.1 per 100k overall 2021, 2.3x national 14.1
- Serious mental illness in AI/AN adults 7.2% past year NSDUH 2020
- Lifetime PTSD in AI/AN women 18.5% vs 9.7% men per AI-SUPERPFP study
- Any anxiety disorder past year 18.9% AI/AN adults estimated
- Bipolar I disorder 12-month prevalence 1.8% AI/AN per NESARC-III
- Schizophrenia spectrum disorders 1.1% lifetime AI/AN
Mental Health Interpretation
Substance Abuse
- Alcohol use disorder affects 15.8% of AI/AN adults past year, 1.5 times national 10.5% per 2021 NSDUH
- AI/AN have opioid overdose death rate of 65.2 per 100,000 in 2021, highest among races at 3.5x white rate
- 28.6% of AI/AN youth aged 12-17 binge drank in past month, vs 13.8% national per 2020 NSDUH
- Methamphetamine use past year among AI/AN adults is 2.7%, higher than 0.9% U.S. average per NSDUH 2021
- AI/AN illicit drug use past month is 25.4% for adults, vs 17.9% nationally per 2021 NSDUH
- Tobacco use daily among AI/AN adults is 28.4%, 1.4x national 19.7% per 2021 NHIS
- AI/AN have highest rate of marijuana use disorder at 4.2% past year vs 2.8% U.S. per NSDUH
- Prescription opioid misuse past year in AI/AN youth 12-17 is 9.1%, double national 4.5% per NSDUH 2020
- Heroin use past year among AI/AN adults 1.8%, vs 0.3% national per 2021 NSDUH
- Fentanyl-involved deaths 40 per 100k AI/AN 2022 provisional
- Binge drinking 30-day past 25.1% AI/AN adults 18+ NSDUH 2021
- Alcohol dependence/abuse 12.7% AI/AN lifetime
- Polysubstance use 15% AI/AN treatment admissions SAMHSA 2021
Substance Abuse Interpretation
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2KIDNEYkidney.orgVisit source
- Reference 3SEERseer.cancer.govVisit source
- Reference 4MCHBmchb.tvisdata.hrsa.govVisit source
- Reference 5SAMHSAsamhsa.govVisit source
- Reference 6PTSDptsd.va.govVisit source
- Reference 7NIMHnimh.nih.govVisit source
- Reference 8DRUGABUSEdrugabuse.govVisit source
- Reference 9KFFkff.orgVisit source
- Reference 10IHSihs.govVisit source
- Reference 11UIHIuihi.orgVisit source
- Reference 12MEPSmeps.ahrq.govVisit source
- Reference 13UAPIuapi.orgVisit source
- Reference 14USRDSusrds.orgVisit source
- Reference 15WONDERwonder.cdc.govVisit source
- Reference 16AJPajp.psychiatryonline.orgVisit source
- Reference 17PUBSpubs.niaaa.nih.govVisit source
- Reference 18NCBIncbi.nlm.nih.govVisit source
- Reference 19URBANurban.orgVisit source
- Reference 20GAOgao.govVisit source
- Reference 21AOAaoa.acdhhs.govVisit source






